Medical Condition News

RSS

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Eli Lilly and Company and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

13 Oct 2015

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

Today, GENALICE is setting a new standard for ultra-fast and highly reliable detection of all DNA changes in large patient cohorts. In a one-hour online event, the complete genomes of 800 Alzheimer Disease (AD) patients were processed, and by ingeniously using the aggregate information from the complete group, detection of DNA changes, or variants, in individual patients was enhanced.

13 Oct 2015

Phase III trial data shows Novartis’ Cosentyx maintains clear skin, sustained efficacy in psoriasis patients

Novartis announced today new late-breaking data demonstrating that CosentyxTM provides high levels of skin clearance and sustained efficacy in patients with moderate-to-severe plaque psoriasis while maintaining a favorable safety profile across three years.

13 Oct 2015

SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland

The Scottish Medicines Consortium has today announced that Xofigo has been accepted for use within NHS Scotland for the treatment of adult patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases.

13 Oct 2015

DePuy Synthes Trauma announces U.S. launch of new biologic implant for trauma-related extremity procedures

DePuy Synthes Trauma announced today the U.S. launch of CONFORM Flex with Q-PACK Technology, the only pre-hydrated demineralized cancellous bone tissue matrix designed for use in trauma-related extremity procedures, including fusion, and for filling bone voids.

13 Oct 2015

Quest Diagnostics scientists demonstrate new molecular combing technique that predicts cystic fibrosis, muscular dystrophy

Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.

From Quest Diagnostics 13 Oct 2015

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it now provides clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx immunohistochemistry test, available through Dako, an Agilent Technologies company.

From Quest Diagnostics 13 Oct 2015

Widespread frustration, dissatisfaction hamper progress for chronic pain sufferers, shows study

Health charity Pain Concern has revealed how widespread frustration and dissatisfaction is stopping people in severe pain getting the support they need from their GP.

13 Oct 2015

New design could improve safety, efficiency of spinal surgery in children with cerebral palsy

Researchers have designed a way to improve the safety and efficiency of a complex surgical procedure for children with cerebral palsy by using wearable technology like Google Glass.

13 Oct 2015

Researchers use high-precision instrument to inject toxins that reduce migraine attacks

Researchers are using a high-precision instrument to inject toxins that alleviate migraine attacks. This means even better needle guidance and user-friendliness.

13 Oct 2015

Finnish researchers find that obesity surgery normalizes brain's opioid neurotransmission

Researchers at Aalto University and University of Turku have revealed how obesity surgery recovers opioid neurotransmission in the brain.

13 Oct 2015

Diabetes screening process needs 'careful re-evaluation'

The process for screening for Type 2 diabetes or those at high risk of the condition needs "careful re-evaluation", according to the first study on the effectiveness of testing methods.

13 Oct 2015

ATA announces research grants to support projects proposed by young researchers

The American Thyroid Association is pleased to announce that grants have been awarded to support projects proposed by leading young researchers. Three of these projects involve the genetic analysis of thyroid tumors carrying the BRAFV600E mutation, which is associated with the development of some forms of thyroid cancer and increased risk for distant metastases, more advanced disease, and higher mortality.

13 Oct 2015

NHS should remove unproven apps from library, say experts

There is no proof that 85% of the depression apps currently recommended by the NHS for patients to manage their condition actually work, say experts in the journal Evidence Based Mental Health.

13 Oct 2015

Penn researchers show that canine X-linked retinitis pigmentosa can be cured over the long term

Three years ago, a team from the University of Pennsylvania announced that they had cured X-linked retinitis pigmentosa, a blinding retinal disease, in dogs. Now they've shown that they can cure the canine disease over the long term, even when the treatment is given after half or more of the affected photoreceptor cells have been destroyed.

13 Oct 2015

Research findings open up new avenues for treatment of people with anorexia nervosa

When people with anorexia nervosa decide what to eat, they engage a part of the brain associated with habitual behavior. This finding by researchers at Columbia University Medical Center, New York State Psychiatric Institute, the Mortimer B. Zuckerman Mind Brain Behavior Institute, and New York University was published today in Nature Neuroscience.

13 Oct 2015

Research: Epigenetic factor reduces sensitivity of breast cancer cells to common cancer drug

A surprising, paradoxical relationship between a tumor suppressor molecule and an oncogene may be the key to explaining and working around how breast cancer tumor cells become desensitized to a common cancer drug, found researchers at the Perelman School of Medicine at the University of Pennsylvania.

13 Oct 2015

Medical Condition News

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

Phase III trial data shows Novartis’ Cosentyx maintains clear skin, sustained efficacy in psoriasis patients

SMC approves Bayer's Xofigo for treatment of castration-resistant prostate cancer in NHS Scotland

DePuy Synthes Trauma announces U.S. launch of new biologic implant for trauma-related extremity procedures

Quest Diagnostics scientists demonstrate new molecular combing technique that predicts cystic fibrosis, muscular dystrophy

Quest Diagnostics provides Dako’s PD-L1 complementary diagnostic test for non-squamous non-small cell carcinoma

Widespread frustration, dissatisfaction hamper progress for chronic pain sufferers, shows study

New design could improve safety, efficiency of spinal surgery in children with cerebral palsy

Researchers use high-precision instrument to inject toxins that reduce migraine attacks

Finnish researchers find that obesity surgery normalizes brain's opioid neurotransmission

Diabetes screening process needs 'careful re-evaluation'

ATA announces research grants to support projects proposed by young researchers

NHS should remove unproven apps from library, say experts

Penn researchers show that canine X-linked retinitis pigmentosa can be cured over the long term

Research findings open up new avenues for treatment of people with anorexia nervosa

Research: Epigenetic factor reduces sensitivity of breast cancer cells to common cancer drug

Gensignia gets CLIA certification to establish clinical laboratory in San Diego

Minority women with subtypes of breast cancer less likely to receive recommended treatment regimens

Females with mild closed-head brain injury more likely to misuse alcohol later in life

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News